Skip to main content

Samlyn Capital, LLC

SEC CIK
0001421097
Latest filing
Aug 14, 2026

DNTH holding history

Dianthus Therapeutics, Inc. in every 13F filed by Samlyn Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DNTH overviewAll 13F holders of DNTHFull Q2 2026 holdings

Shares (Q2 2026)
196,326
Value
$19.1M
% of portfolio
0.3%
Quarters held
2
Since Q1 2026
Holdings of DNTH by Samlyn Capital, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026196,326$19.1M0.3%−234,789−54.5%ReducedHolders
Q1 2026431,115$36.2M0.6%+431,115NewHolders